Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

New computational protocol accelerates drug discovery for Chagas disease

25

Apr 2026

New computational protocol accelerates drug discovery for Chagas disease

Researchers at the University of Kent have established a computational protocol that could accelerate the development of more effective treatments for life-threatening parasitic infections such as Chagas disease, by enabling scientists to accurately identify reactions that can result in successful drug candidates without the need for trial and error.

Yōni.Fit expands use for menstrual discharge management

24

Apr 2026

Yōni.Fit expands use for menstrual discharge management

Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative solutions for women's pelvic health, today announced the Company has added a second indication for its flagship product, the Yōni.Fit Bladder Support ("Yōni.Fit").

Media coverage and campaigns drove decline in youth vaping

24

Apr 2026

Media coverage and campaigns drove decline in youth vaping

Researchers from the University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science have found that both anti-vaping advertising and widespread news coverage of a lung-injury outbreak tied to vaping - known as e-cigarette or vaping product use-associated lung injury (EVALI) - were critical in making 2019 a turning point in youth vaping prevalence in the United States.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.